# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Bill Kirk maintains Carlyle Group (NASDAQ:CG) with a Hold and lowers the price target from $45 to $41.
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt...
Deal would value the Baxter spinoff at more than $4 billionhttps://www.wsj.com/finance/investing/carlyle-in-advanced-talks-to-a...
KKR reportedly aims to raise $20 billion for its new North America private equity fund, North America Fund XIV. This fund targe...
- CNBC
Blackstone, Ares Management Group, Carlyle Group and even energy drink conglomerate Red Bull have eyed sports deals.
-Reuters
Red Bull already owns two Formula 1 teams and Major League Soccer's New York Red Bulls, among other sports-related investme...